HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 132012Erstellt: 25. Oktober 2026
4-[1-(4-chloro-3-nitrophenacyl)-1H-benzimidazol-2-yl]-furazan-3-ylamine → 4-[1-(3-Amino-4-chlorophenacyl)-1H-benzimidazol-2-yl]-furazan-3-ylamine
https://huagongshe.com/reaction/132012
Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|
| Edukt | 4-[1-(4-chloro-3-nitrophenacyl)-1H-benzimidazol-2-yl]-furazan-3-ylamine | HCID 67459004 | — |
| Katalysator | Hydrochloric Acid | HCID 313 | — |
| Katalysator | Iron | HCID 23925 | — |
| Lösungsmittel | Ethanol | HCID 702 | — |
| Lösungsmittel | Water | HCID 962 | — |
| Produkt | 4-[1-(3-Amino-4-chlorophenacyl)-1H-benzimidazol-2-yl]-furazan-3-ylamine | HCID 67460747 | — |
Reaktionsschritte
To a stirred solution of 4-[1-(4-chloro-3-nitrophenacyl)-1H-benzimidazol-2-yl]-furazan-3-ylamine (0.07 g, 0.175 mmol) in ethanol (6 ml) and water (1 ml) is added two drops of concentrated hydrochloric acid and iron powder (0.1 g, 17.5 mmol). The reaction mixture is heated at 80° C. for 8 hours. Filtration and evaporation at reduced pressure gives the crude product. Purification by extraction with ethyl acetate and chromatography on silicagel yields the title compound as colorless solid, m.p. 228-230° C.
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patentnummer | US07385061B2 |
|---|
| Quelldatensatz | uspto-grants-2008_06 |
|---|
| ORD ID | ord-878682249689446a9403df1cab3f83da |
|---|
| Quellennotiz | uspto-grants-2008_06 |
|---|